[1] Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis[J]. J Am Coll Cardiol, 2012, 59(9): 779-792. [2] 丁国雷, 韩丽娜, 王玉堂, 等. 一氧化氮合酶抑制剂治疗实验性自身免疫性心肌炎的研究[J]. 中国应用生理学杂志, 2013, 29(2): 195-163. [3] Passino C, Barison A, Vergaro G, et al. Markers of fibrosis, inflammation, and remodeling pathways in heart failure[J]. Clinica Chimica Acta, 2015, 443: 29-38. [4] Yi C, Wang SJ.Hypericin, the active component of St.John’s wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitiogen-activated protein kinase-dependent pathway[J]. Eur J Pharmacol, 2010, 634: 53-61. [5] 李 乐, 张益灵, 陶厚权. 贯叶连翘提取物对小鼠免疫性心肌炎的作用[J]. 中国应用生理学杂志, 2013, 29(4): 336-338. [6] Akahori H, Tsujino T, Naito Y, et al. Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats[J]. J Hypertens, 2014, 32(7): 1534-1541. [7] Leuschner F,Katus HA,Kaya Z.Autoimmune myocarditis: past, present and future[J]. J Autoimmun, 2009, 33(3-4): 282-289. [8] Querejeta R, Lopez B, Gonzalez A, et al.Increased collagen type I synthesis in patients with heart failure of hypertensiveorigin: relation to myocardial fibrosis[J]. Circulation, 2004, 110(10): 1263-1268. [9]Lepojärvi ES, Piira OP, Pääkkö E, et al. Serum PINP, PIIINP, galectin-3, and ST2 as surrogates of myocardial fibrosis and echocardiographic left venticular diastolic filling properties[J]. Front Physiol, 2015, 6: 200-206. [10]陈 姝. 卡托普利药物的应用及作用机制分析[J]. 临床医药文献杂志, 2016, 3(1): 189-191. [11]Duan Y, Zhu W, Liu M, et al. The expression of Smad signaling pathway in myocardium and potential therapeutic effects[J]. Histol Histopathol, 2017, 32(7): 651-659. [12]裴宸晨, 李 乐. 贝母提取物对异丙肾上腺素致小鼠心肌纤维化的作用[J]. 中国应用生理学杂志, 2018, 34(1): 48-49. [13]Dobaczewski M, Chen W, Frangogiannis NG.Transforming growth factor(TGF)-β signaling in cardiac remodeling[J]. J Mol Cell Cardiol, 2011, 51(4): 600-606. |